Kirby Corporation
KEX
$146.07
+6.57%
Kirby Corporation is the largest domestic operator of inland tank barges and towing vessels in the United States, moving petrochemicals, refined products, black oil, and other bulk liquid cargoes across the Mississippi River system, Gulf Intracoastal Waterway, and three U.S. coasts, while its smaller Distribution and Services segment provides aftermarket parts, engines, transmissions, and power generation equipment for oilfield, marine, and industrial customers. The company's competitive identity rests on the scale and density of its barge fleet and a duopoly-like inland marine structure that creates high barriers to entry, pricing discipline, and a reputation as the sector's benchmark operator. The current investor narrative centers on a powerful multi-year margin recovery — operating margins have climbed from roughly 8% in early 2023 to the mid-teens by late 2025 — driven by barge utilization, term-contract repricing, and disciplined capital allocation, with the debate now focused on whether earnings momentum can persist as the stock has pulled back from its highs. Recent news flow is thin and largely administrative, including insider profit-taking and board changes, leaving the fundamental earnings trajectory and inland barge supply-demand dynamics as the primary drivers of sentiment.…
KEX
Kirby Corporation
$146.07
Related headlines
Investment Opinion: Should I buy KEX Today?
Rating: Buy (accumulate on weakness). The thesis is that Kirby's margin recovery is structurally intact — operating margins have roughly doubled from the 6.3% trough in Q4 2024 to the mid-teens — while the stock trades at only 16.1x forward earnings, and all 7 analysts rate it strong buy with a $169 average target implying about 27% upside from $133.15. The recent 18.4% pullback from the $157.69 high looks like consolidation within an uptrend rather than a broken thesis, given the +55.1% one-year return and +42-point relative outperformance versus SPY.
The supporting evidence is broad: Q1 2026 revenue grew 7.4% year-over-year to $844.1M, TTM free cash flow of $497M implies roughly 12x price/FCF, net margin is 10.5%, and the balance sheet carries debt-to-equity of just 0.39 with a 1.53 current ratio. The PEG ratio of 0.60 and EV/EBITDA of 9.4x are undemanding for a business with duopoly economics and contracted revenue. Analyst EPS estimates of $9.60 average (range $9.38-$9.83) imply the forward PE of 16.1x is based on realistic, tightly clustered numbers rather than an outlier forecast.
The risks that could invalidate the thesis are: (1) sequential margin erosion continuing — Q1 2026 operating margin of 12.6% versus 15.0% in Q4 2025 — which would pressure the $9.60 EPS estimate; (2) a petrochemical demand slowdown reducing barge utilization and spot rates; and (3) technical breakdown below the $128.88 support, which would open the mid-$110s. The rating would upgrade to a stronger Buy if Q2 2026 operating margin recovers above 14% and revenue exceeds $860M, and would downgrade to Hold if operating margin falls below 11% or revenue growth decelerates below 5%. On balance, KEX is fairly valued to modestly undervalued relative to its earnings power and clearly undervalued relative to analyst targets, but not a deep-value bargain.
Sign up to view all
KEX 12-Month Price Forecast
The forward view is constructive but not without caveats. Kirby's earnings power has structurally improved — operating income more than doubled year-over-year in Q4 — and the stock's 16.1x forward PE with a 0.60 PEG leaves room for re-rating toward the $169 consensus target. The main uncertainty is the sequential softening in Q1 2026, where operating margin fell to 12.6% from 15.0%; if that proves seasonal, the base case of $155-$175 is well supported, but if it marks the start of margin rollover, the bear case toward the mid-$110s becomes live. The low beta of 0.84 and strong free cash flow make the risk/reward favorable for patient investors. I would upgrade to high confidence if Q2 2026 operating margin recovers above 14%, and downgrade to neutral if it falls below 11% or revenue growth drops under 5%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Kirby Corporation's 12-month outlook, with a consensus price target around $169.00 and implied upside of +15.7% versus the current price.
Average Target
$169.00
0 analysts
Implied Upside
+15.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$156 - $200
Analyst target range
Bulls vs Bears: KEX Investment Factors
The bull case rests on a genuine, multi-year margin recovery — operating margins have expanded from 6.3% in Q4 2024 to the mid-teens, EPS has more than doubled year-over-year, and all 7 analysts rate the stock a strong buy with a $169 average target implying 27% upside at a modest 16.1x forward PE. The bear case is that the recovery is already maturing: EPS and revenue declined sequentially in Q1 2026, revenue growth is only 7.4%, and the stock has lost 18.4% from its high with -13.3 points of three-month relative underperformance. On balance the fundamental evidence (earnings trajectory, cash flow, balance sheet, analyst consensus) is stronger than the technical evidence, which is why the debate hinges on one question: whether the Q1 2026 sequential softness is seasonal noise or the start of margin rollover. That single factor — the direction of Marine segment operating margin in the next two quarters — will determine whether KEX re-tests $157 or drifts toward the mid-$110s.
Bullish
- Earnings recovery is real and steep: Quarterly diluted EPS rose from $0.74 in Q4 2024 to $1.68 in Q4 2025 and $1.50 in Q1 2026, while operating income jumped from $50.1M to $127.9M over the same Q4-to-Q4 comparison. The Q1 2026 operating margin of 12.6% and Q4 2025's 15.0% are a step-change from the 6.3% operating margin posted in Q4 2024.
- Analyst targets imply large upside: All 7 covering analysts carry a 'strong_buy' consensus (mean rating 1.14) with an average target of $169 versus the $133.15 price — roughly 27% upside. Even the low target of $156 sits about 17% above the current price, meaning no analyst's published target is below today's quote.
- Valuation is modest for the growth: At a trailing PE of 17.3x and forward PE of 16.1x, KEX trades at a discount to the broader industrial/marine complex, while the PEG ratio of 0.60 and EV/EBITDA of 9.4x suggest the market is not paying up for the earnings ramp. A 10.5% net margin and 14.6% operating margin support that multiple.
- Cash generation and balance sheet are solid: TTM free cash flow of $497M against a $6.1B market cap implies a price/FCF of roughly 12x, and the 9.2x PCF ratio is undemanding. Debt-to-equity of 0.39 and a current ratio of 1.53 leave ample room to fund barge capex without dilution.
Bearish
- Momentum has clearly broken down: Despite the +55.1% one-year gain, the stock is down 10.4% over three months and 11.6% over six months, with relative strength versus SPY at -13.3 and -18.0 points respectively. At $133.15 it sits 18.4% below the $157.69 52-week high, having failed repeatedly in the $145-$150 zone.
- Sequential earnings are already softening: Diluted EPS fell from $1.68 in Q4 2025 to $1.50 in Q1 2026, and operating income dropped from $127.9M to $106.2M quarter-over-quarter. Revenue of $844.1M was below Q4 2025's $851.8M and Q3 2025's $871.2M, suggesting the margin-recovery tailwind is decelerating.
- Growth is slow relative to the narrative: Q1 2026 revenue grew only 7.4% year-over-year, and gross margin slipped to 25.7% from 26.7% a year earlier. A PEG of 0.60 looks attractive only if the ~$9.60 consensus EPS is achieved; that requires roughly 25% EPS growth off a base that is already showing sequential declines.
- Insider selling and thin news flow: The CIO sold nearly 4,000 shares, cutting his personal stake by more than 50%, alongside a board change. With little other news flow, the absence of insider buying near a 18% drawdown from highs is a soft negative signal on management's own view of near-term value.
KEX Technical Analysis
Kirby is in a powerful longer-term uptrend that has recently entered a corrective consolidation phase. The stock is up 55.08% over the past year and 18.99% year-to-date, yet at $133.15 it sits at roughly 66.1% of its 52-week range of $85.67 to $157.69 — meaning it has surrendered a meaningful portion of its gains from the highs but remains far above the lows. This positioning suggests a stock digesting a large advance rather than one breaking down, though the failure to hold the upper end of the range leaves the trend vulnerable to further mean reversion. The 52-week high of $157.69 is now about 18.4% above the current price, a wide gap that underscores how much momentum has faded since the peak.
Short-term momentum is mixed and diverging from the longer-term trend. The stock is up 2.39% over the past month, outperforming the S&P 500's -1.02% by 3.41 percentage points, but it is down 10.43% over three months and 11.59% over six months — a stark deceleration against the +55.08% one-year gain. That divergence signals the uptrend has stalled and the stock is in a corrective or range-bound phase rather than a fresh leg higher. The recent bounce from the late-September low of $128.88 to $133.15 is encouraging, but the 3-month relative strength of -13.28 percentage points versus SPY confirms Kirby has lagged the market during this consolidation.
Key technical levels are well defined. Support sits at the 52-week low of $85.67, with a nearer intermediate floor around the recent $128.88-$131.50 zone; resistance is the 52-week high of $157.69, with the $145-$150 area acting as a secondary ceiling given the July and August highs. A breakout above $157.69 would confirm trend resumption and likely target new highs, while a breakdown below $128.88 would signal a deeper correction toward the mid-$110s. With a beta of 0.84, Kirby is roughly 16% less volatile than the market, which supports larger position sizing for risk-tolerant investors, though the 4.89 short ratio and 566,948 daily volume indicate moderate liquidity and some short interest that could amplify moves.
Beta
0.84
0.84x market volatility
Max Drawdown
-15.5%
Largest decline past year
52-Week Range
$93-$158
Price range past year
Annual Return
+64.8%
Cumulative gain past year
| Period | KEX Return | S&P 500 |
|---|---|---|
| 1m | +11.0% | +0.9% |
| 3m | +10.4% | +4.1% |
| 6m | -0.8% | +7.2% |
| 1y | +64.8% | +12.4% |
| ytd | +30.5% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KEX Fundamental Analysis
Quarterly Revenue
$844099000.0B
2026-03
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
25.8%
Latest Quarter
Free Cash Flow
$497139000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KEX Overvalued?
PE
17.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 13x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the durability of the margin recovery. Q1 2026 operating income of $106.2M was down from $127.9M in Q4 2025, and operating margin fell from 15.0% to 12.6% sequentially, showing that earnings are sensitive to barge utilization and term-contract timing. Revenue is heavily concentrated in the Marine Transportation segment, which ties results to petrochemical and refined-product volumes along the Mississippi system; a single soft quarter in that segment can move consolidated EPS materially, as the swing from $0.74 to $1.68 in Q4 comparisons demonstrates. Interest expense of $10.3M per quarter on debt-to-equity of 0.39 is manageable, but the company carries meaningful fixed asset intensity in its barge fleet, so any utilization decline hits operating leverage quickly. Cash flow is a strength — $497M TTM free cash flow — but capex requirements to maintain and grow the fleet could compress that if replacement costs rise.
Market and competitive risks are primarily valuation and cyclicality. At 17.3x trailing and 16.1x forward earnings, KEX is not expensive in absolute terms, but the market is pricing in the consensus $9.60 EPS; if that estimate slips toward the low end of $9.38 or below, the multiple would expand on realized earnings and the stock could de-rate. Beta of 0.84 offers some insulation, but inland barge demand is tied to chemical and refining activity, making the stock sensitive to industrial production cycles and energy capex. The duopoly structure with a primary competitor supports pricing discipline, but new barge deliveries or a demand slowdown could pressure spot rates. Recent news flow is thin and administrative — insider selling and a board change — which leaves sentiment vulnerable to headline risk and offers no positive catalyst to offset the technical breakdown.
The worst-case scenario is a synchronized downturn: petrochemical volumes weaken, term contracts reprice lower, and Q2/Q3 2026 margins fall back toward the high-single digits, invalidating the $9.60 EPS consensus. In that case the stock would likely retest the $128.88 September low first, then the 52-week low of $85.67 — a decline of roughly 36% from the current $133.15. Even a milder de-rating to the analyst low target of $156 is not a downside case, so the realistic bear path is toward the mid-$110s (about -15%) if support at $128.88 breaks, with a tail risk to $85.67 if the margin story fully unwinds. The recorded 15.5% max drawdown is a reminder that this stock can correct sharply even in an uptrend.
FAQ
The most severe risk is margin rollover: Q1 2026 operating margin of 12.6% was down from 15.0% in Q4 2025, and a continuation would pressure the $9.60 EPS consensus. Second is demand cyclicality — revenue is concentrated in Marine Transportation tied to petrochemical and refining volumes, so an industrial slowdown hits utilization and spot rates directly. Third is technical breakdown risk: a close below the $128.88 September low would likely target the mid-$110s, with a tail scenario toward the $85.67 52-week low (about -36%). Fourth is sentiment and liquidity — a 4.89 short ratio and thin news flow, combined with insider selling by the CIO, leave the stock vulnerable to headline-driven moves.
The 12-month forecast has three scenarios: a base case (55% probability) of $155-$175 assuming margins stabilize in the low-to-mid teens and EPS reaches the $9.60 consensus, a bull case (25%) of $180-$200 if operating margins recover above 15% and the multiple expands toward the analyst high target, and a bear case (20%) of $100-$128 if petrochemical demand weakens and margins fall back toward high-single digits. The base case is most likely because it requires only that the Q1 2026 sequential dip prove seasonal, which the Q4 2025 15.0% margin and $497M TTM free cash flow support. The key assumption is that inland barge pricing discipline holds and no new capacity disrupts the duopoly.
KEX trades at 17.3x trailing and 16.1x forward earnings, 9.4x EV/EBITDA, 1.8x sales, and 1.8x book, with a PEG of 0.60 — a modest multiple for a business with duopoly economics and a 10.5% net margin. Relative to its own history during the margin-recovery phase, the stock has de-rated from its $157.69 high even as earnings rose, which is why the forward multiple now looks reasonable rather than stretched. The market appears to be pricing in the $9.60 consensus EPS but not much beyond it, implying skepticism about further margin expansion. If margins hold in the low-to-mid teens, the stock is fairly valued to modestly undervalued; a return to 18-20x forward earnings would justify the $180-$200 bull case.
From a risk/reward perspective, KEX offers roughly 27% upside to the $169 average analyst target against a realistic downside of about 15% to the mid-$110s if the $128.88 support breaks, a favorable ratio for a low-beta (0.84) industrial. The 16.1x forward PE on tightly clustered consensus EPS of $9.38-$9.83 is undemanding, and all 7 analysts rate it strong buy. The biggest downside risk is continued sequential margin erosion — Q1 2026 operating margin fell to 12.6% from 15.0% in Q4 2025. It is a good buy for investors with a 12-24 month horizon who can tolerate a cyclical drawdown, particularly on weakness toward $128 or below; it is less suited to short-term traders given the -10.4% three-month momentum.
KEX is better suited to a medium-to-long-term holding period of at least 12-24 months. The company pays no dividend (0% payout), so total return depends entirely on earnings growth and multiple re-rating, which takes time to play out through contract repricing cycles. Beta of 0.84 and a 15.5% max drawdown indicate moderate volatility — enough to punish short-term entries during corrections like the current 18.4% pullback, but manageable for long-term holders. Earnings visibility is reasonably good given the contracted revenue base and tight analyst EPS range of $9.38-$9.83. Short-term traders should wait for a reclaim of $145-$150 or a confirmed bounce off $128.88 before entering.